In tracheal adenoid cystic carcinoma, half are type II (PD-L1-/CD8-, immunologic ignorance) or type IV (PD-L1-/CD8+, tolerance) (20). This evidence concerns the gene CD8A and tracheal adenoid cystic carcinoma.